Kalaris Therapeutics, Inc. (KLRS)
4.15
+0.07
(+1.72%)
USD |
NASDAQ |
Aug 27, 16:00
4.15
0.00 (0.00%)
After-Hours: 20:00
Kalaris Therapeutics EPS Diluted (TTM) : -2.014 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.014 |
| March 31, 2026 | -2.137 |
| December 31, 2025 | -4.195 |
| September 30, 2025 | -20.00 |
| June 30, 2025 | -47.52 |
| March 31, 2025 | -51.18 |
| December 31, 2024 | -108.36 |
| September 30, 2024 | -104.17 |
| June 30, 2024 | -84.95 |
| March 31, 2024 | -91.69 |
| December 31, 2023 | -42.14 |
| September 30, 2023 | -39.52 |
| June 30, 2023 | -41.97 |
| March 31, 2023 | -46.89 |
| December 31, 2022 | -52.50 |
| Date | Value |
|---|---|
| September 30, 2022 | -64.05 |
| June 30, 2022 | -69.28 |
| March 31, 2022 | -67.22 |
| December 31, 2021 | -62.89 |
| September 30, 2021 | -51.29 |
| June 30, 2021 | -48.08 |
| March 31, 2021 | -38.33 |
| December 31, 2020 | -30.19 |
| September 30, 2020 | -23.92 |
| June 30, 2020 | -13.07 |
| March 31, 2020 | -10.83 |
| December 31, 2019 | -8.422 |
| September 30, 2019 | -5.333 |
| June 30, 2019 | -2.765 |
| March 31, 2019 | -0.8917 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Replimune Group, Inc. | -3.279 |
| Arrowhead Pharmaceuticals, Inc. | -2.243 |
| Oncolytics Biotech, Inc. | -0.2725 |
| Sangamo Therapeutics, Inc. | -0.383 |
| Sarepta Therapeutics, Inc. | -2.898 |